<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Huhtamaki India Ltd. (HUHTAMAKI) — Tipsheet</title>
    <link>https://tipsheet.markets/company/huhtamaki/</link>
    <atom:link href="https://tipsheet.markets/company/huhtamaki/feed.xml" rel="self" type="application/rss+xml" />
    <description>Every Tipsheet Editorial note covering Huhtamaki India Ltd. (HUHTAMAKI), newest first. Grounded in BSE/NSE primary-source filings.</description>
    <language>en-in</language>
    <lastBuildDate>Tue, 28 Jul 2026 14:38:34 GMT</lastBuildDate>
    <item>
      <title>Huhtamaki India sales jump 23%, but warns of inventory boost</title>
      <link>https://tipsheet.markets/huhtamaki-huhtamaki-india-sales-jump-23-but-warns-of-inventory-boost-128028/</link>
      <guid isPermaLink="true">https://tipsheet.markets/huhtamaki-huhtamaki-india-sales-jump-23-but-warns-of-inventory-boost-128028/</guid>
      <pubDate>Mon, 27 Jul 2026 16:48:03 GMT</pubDate>
      <description>Q2 CY26 sales of ₹723 cr and EBITDA margin of 10.5% beat prior trend, but management says part of the growth came from customer stockpiling ahead of price rises and could unwind. Renewable energy project delayed.</description>
      <content:encoded><![CDATA[<p><em>Q2 CY26 sales of ₹723 cr and EBITDA margin of 10.5% beat prior trend, but management says part of the growth came from customer stockpiling ahead of price rises and could unwind. Renewable energy project delayed.</em></p>
<h3>What’s new</h3><ul><li>Q2 CY26 sales ₹723 cr, up 23.1% YoY; EBITDA margin 10.5%.</li><li>Growth partly from inventory buildup ahead of price hikes; reversal possible.</li><li>Renewable energy project delayed to Q3 CY26.</li></ul>
<h3>Why it matters</h3><p>The 23% growth is a sharp acceleration from near-zero trailing revenue, but the inventory-driven tailwind raises questions about sustainability. The focus on profitable growth over volume is prudent, but it likely means moderation ahead. The margin, though improved, remains moderate.</p>
<h3>What we’re watching</h3><ul><li>Q3 sales to see if the inventory boost reverses.</li><li>Renewable energy project commissioning and its cost impact.</li><li>Margin trajectory amid raw material cost moves.</li></ul>
<h3>The full read</h3><p>Huhtamaki India delivered <strong>₹723 cr</strong> in Q2 CY26 sales, a <strong>23.1%</strong> year-on-year surge. EBITDA margin came in at <strong>10.5%</strong>. These are strong numbers. But management's cautionary tint is the real story: part of the jump came from customers stockpiling ahead of price increases, and some of that benefit could reverse as Middle East crisis-related stocking normalises. A renewable energy project originally due in Q2 is now delayed to Q3, pushing out cost savings. It is a strong quarter. But the sustainability question hangs over it. The company says it is prioritising profitable growth, which is the right call, but it means the headline growth rate may not hold. For a firm with near-zero trailing revenue growth, this acceleration is a welcome reprieve but one that carries a built-in reversal risk.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=509820&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=HUHTAMAKI">NSE</a></p>]]></content:encoded>
      <category>Concalls</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
  </channel>
</rss>